180 related articles for article (PubMed ID: 25997138)
1. Intravenous contrast material and acute kidney injury: a need for caution.
Mirrakhimov AE; Mirrakhimov EM
Radiology; 2015 Jun; 275(3):931. PubMed ID: 25997138
[No Abstract] [Full Text] [Related]
2. No Association between Intravenous Contrast Material Exposure and Adverse Clinical Outcome: Are Prevention Protocols Effective?
Gramberg MC; Penne EL
Radiology; 2015 Oct; 277(1):306. PubMed ID: 26402500
[No Abstract] [Full Text] [Related]
3. Response.
McDonald RJ; McDonald JS; Carter RE; Hartman RP; Katzberg RW; Kallmes DF; Williamson EE
Radiology; 2015 Oct; 277(1):306-7. PubMed ID: 26668855
[No Abstract] [Full Text] [Related]
4. Response.
McDonald RJ; McDonald JS; Carter RE; Hartman RP; Katzberg RW; Kallmes DF; Williamson EE
Radiology; 2015 Jun; 275(3):931-2. PubMed ID: 26199958
[No Abstract] [Full Text] [Related]
5. Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality.
McDonald RJ; McDonald JS; Carter RE; Hartman RP; Katzberg RW; Kallmes DF; Williamson EE
Radiology; 2014 Dec; 273(3):714-25. PubMed ID: 25203000
[TBL] [Abstract][Full Text] [Related]
6. Incidences of acute kidney injury, dialysis, and graft loss following intravenous administration of low-osmolality iodinated contrast in patients with kidney transplants.
Fananapazir G; Troppmann C; Corwin MT; Nikpour AM; Naderi S; Lamba R
Abdom Radiol (NY); 2016 Nov; 41(11):2182-2186. PubMed ID: 27377897
[TBL] [Abstract][Full Text] [Related]
7. Contrast-induced nephropathy in outpatients with preexisting renal impairment: a comparison between intravenous iohexol and iodixanol.
Cernigliaro JG; Haley WE; Adolphson DP; Jepperson MA; Crook JE; Thomas CS; Parker AS
Clin Imaging; 2016; 40(5):902-6. PubMed ID: 27183138
[TBL] [Abstract][Full Text] [Related]
8. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study.
Chuang FR; Chen TC; Wang IK; Chuang CH; Chang HW; Ting-Yu Chiou T; Cheng YF; Lee WC; Chen WC; Yang KD; Lee CH
Ren Fail; 2009; 31(3):181-8. PubMed ID: 19288321
[TBL] [Abstract][Full Text] [Related]
9. Clinical and nephrologic tolerance of iopromide and iotrolan in computed tomography.
Langer M; Langer R; Zwicker C; Speck U; Jänicke UA; Felix R
Invest Radiol; 1991 Nov; 26 Suppl 1():S83-5; discussion S88-91. PubMed ID: 1808156
[No Abstract] [Full Text] [Related]
10. Comparison of the nephrotoxicity between ioversol and iohexol.
Hayami S; Ishigooka M; Suzuki Y; Hashimoto T; Nakada T; Mitobe K
Int Urol Nephrol; 1996; 28(5):615-9. PubMed ID: 9061418
[TBL] [Abstract][Full Text] [Related]
11. Renal effects of nonionic contrast media after intravenous cardiac, and lumbar aortic injections.
Jakobsen JA; Kolbenstvedt AN; Levorstad K; Berg KJ; Enge I
Invest Radiol; 1990 Sep; 25 Suppl 1():S135-6. PubMed ID: 2283233
[No Abstract] [Full Text] [Related]
12. Is the use of intravenous contrast material truly safe in patients with impaired renal function?
Cohen MD
Radiology; 2009 May; 251(2):613; author reply 613-4. PubMed ID: 19401587
[No Abstract] [Full Text] [Related]
13. The rabbit renal toxicity test: a sensitive in vivo test for the nephrotoxicity of contrast agents.
Pettersson G; Towart R; Grant D; Thyberg K; Golman K
Acad Radiol; 2002 May; 9 Suppl 1():S62-4. PubMed ID: 12019897
[No Abstract] [Full Text] [Related]
14. Within-hospital and 30-day outcomes in 107,994 patients undergoing invasive coronary angiography with different low-osmolar iodinated contrast media.
LaBounty TM; Shah M; Raman SV; Lin FY; Berman DS; Min JK
Am J Cardiol; 2012 Jun; 109(11):1594-9. PubMed ID: 22440116
[TBL] [Abstract][Full Text] [Related]
15. Rate of major adverse renal or cardiac events with iohexol compared to other low osmolar contrast media during interventional cardiovascular procedures.
McCullough PA; Todoran TM; Brilakis ES; Ryan MP; Gunnarsson C
Catheter Cardiovasc Interv; 2019 Feb; 93(2):E90-E97. PubMed ID: 30280476
[TBL] [Abstract][Full Text] [Related]
16. Contrast-agent-induced acute renal dysfunction--is iodixanol the answer?
Sandler CM
N Engl J Med; 2003 Feb; 348(6):551-3. PubMed ID: 12571263
[No Abstract] [Full Text] [Related]
17. Selective injection of iopentol, iohexol and metrizoate into the left coronary artery of the dog. Induction of ventricular fibrillation and decrease of aortic pressure.
Almén T; Bååth L
Acta Radiol Suppl; 1987; 370():65-8. PubMed ID: 2980315
[TBL] [Abstract][Full Text] [Related]
18. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
[TBL] [Abstract][Full Text] [Related]
19. Influence of the timing of cardiac catheterization and the amount of contrast media on acute renal failure after cardiac surgery.
Ranucci M; Ballotta A; Kunkl A; De Benedetti D; Kandil H; Conti D; Mollichelli N; Bossone E; Mehta RH
Am J Cardiol; 2008 Apr; 101(8):1112-8. PubMed ID: 18394443
[TBL] [Abstract][Full Text] [Related]
20. Exposure to low- vs iso-osmolar contrast agents reduces NADPH-dependent reactive oxygen species generation in a cellular model of renal injury.
Netti GS; Prattichizzo C; Montemurno E; Simone S; Cafiero C; Rascio F; Stallone G; Ranieri E; Grandaliano G; Gesualdo L
Free Radic Biol Med; 2014 Mar; 68():35-42. PubMed ID: 24300339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
